Evidence map›Paper›PMID 31925414›Full record

Trial reportAnnals of behavioral medicine : a publication of the Society of Behavioral Medicine2020

Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes.

Alla Sikorskii, Charles W Given, Barbara A Given, Asish Banik, John C Krauss

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02043184 (Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02043184 nacompletednot on this map

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

TypeinterventionalSponsorMichigan State UniversityRan2013 to 2016Enrolled322ConditionsProstatic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, MelanomaArmsInteractive Voice Response (IVR) Reminders
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alla SikorskiiDepartment of Psychiatry and Department of Statistics and Probability, Michigan, State University, East Lansing, MI, USA.
Charles W GivenCollege of Nursing, Michigan State University, East Lansing, MI, USA.
Barbara A GivenCollege of Nursing, Michigan State University, East Lansing, MI, USA.
Asish BanikDepartment of Statistics and Probability, Michigan State University, East Lansing, MI, USA.
John C KraussDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Michigan State University · USUniversity of Michigan · US

Funding

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVRR01CA162401 · NCI · MICHIGAN STATE UNIVERSITY · PI GIVEN, BARBARA ANN, GIVEN, CHARLES W · 2013 to 2016
$2.3M
NCI NIH HHS R01 CA162401
6 · The paper itself

Abstract

backgroundSelf-management of symptoms related to cancer and its treatment is important for maintaining treatment regimens and improving outcomes. PURPOSE: To determine factors associated with engagement in a symptom self-management intervention among patients initiating oral anticancer treatment.

methodsThis secondary analysis included 127 patients randomized to the medication adherence reminder and symptom management intervention in a recently completed trial. Patients were recruited from six Comprehensive Cancer Centers, interviewed at intake, and mailed a Symptom Management Toolkit (Toolkit) with self-care management strategies for 18 symptoms. During eight automated telephone weekly calls, patients were asked to use the Toolkit to manage elevated symptoms. Toolkit use and symptoms were tracked weekly, and generalized linear mixed-effects models were used to determine factors predictive of Toolkit use. General linear modeling was used to relate the Toolkit use during intervention to postintervention symptom severity.

resultsBetter cognitive function at intake into the trial and higher symptom burden were predictive of the patients' initial decision to try the Toolkit during Week 1. In subsequent weeks, Toolkit use in the previous week and worsening of symptoms were associated with greater odds of Toolkit use. The extent of Toolkit use modified the relationship between intake and 8 week symptom severity: among patients with higher levels of severity at intake, use of the Toolkit conferred greater benefit at 8 weeks.

conclusionsPatients make realistic decisions regarding when to use a self-directed approach to self-management and are likely to use strategies when their symptoms are higher and to forego use once symptoms subside. CLINICAL

trial registrationNCT02043184.

Indexed as

Patient ParticipationReminder SystemsAdministration, OralAgedAntineoplastic AgentsFemaleHumansMaleManuals as TopicMedication AdherenceMiddle AgedNeoplasmsSelf-ManagementSeverity of Illness IndexTelephoneAntineoplastic AgentsCancerInterventionOral agentsSelf-managementSymptoms

Identifiers

PMID31925414
PMCPMC7291323
OpenAlexW3000034547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.